http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61243017-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb2488db6534ccbba4026700100c6ba3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-44 |
| filingDate | 1985-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14e97df87f167f3b81191e33c50cffa5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b58c38f09bcf3b7bea0e11b1ca80a0d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbdab6dcd3155ffc26aa00c76c691d63 |
| publicationDate | 1986-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-S61243017-A |
| titleOfInvention | Carcinogenic promoter inhibitor |
| abstract | PURPOSE: The titled inhibitor, containing a modified glycyrrhetinic acid com pound as an active constituent without developing pseudoaldosteronism which is a side effect. n CONSTITUTION: A carcinogenic promoter inhibitor containing a modified glycyrrhetinic acid compound expressed by formula I [X is residue of a compound expressed by formula II, III or IV; R 1 and R 2 are H or may be acylated by a monocarboxylic acid or dicarboxylic acid, and the free acid of the product is used directly in the case of the dicarboxylic acid of may be converted into an acid addition salt] as an active constituent. The does thereof is preferably 30W750mg/human/day for oral administration and about 60% above-mentioned amount for parenteral administration. The dosage form is powder, granule, tablet, sugar-coated table,t capsule, etc. as an oral agent, and a solvent, e.g. water, propylene glycol or polyethylene glycol, is used for an injection. Furthermore, 2% solution or ointment is used as an agent for external use. n COPYRIGHT: (C)1986,JPO&Japio |
| priorityDate | 1985-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.